These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Steroid metabolome profiling of follicular fluid in normo- and hyperandrogenic women with polycystic ovary syndrome. Yang Z, Zhou W, Zhou C, Zhou Y, Liu X, Ding G, Hu Y, Pan J, Sheng J, Jin L, Huang H. J Steroid Biochem Mol Biol; 2021 Feb; 206():105806. PubMed ID: 33340681 [Abstract] [Full Text] [Related]
3. Ovarian Expression of Adipokines in Polycystic Ovary Syndrome: A Role for Chemerin, Omentin, and Apelin in Follicular Growth Arrest and Ovulatory Dysfunction? Bongrani A, Mellouk N, Rame C, Cornuau M, Guérif F, Froment P, Dupont J. Int J Mol Sci; 2019 Aug 02; 20(15):. PubMed ID: 31382403 [Abstract] [Full Text] [Related]
7. In utero exposure to maternal stressful life events and risk of polycystic ovary syndrome in the offspring: The Raine Study. Koch T, Doherty DA, Dickinson JE, Juul A, Hart R, Bräuner EV, Hickey M. Psychoneuroendocrinology; 2021 Mar 02; 125():105104. PubMed ID: 33352473 [Abstract] [Full Text] [Related]
11. Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry. Keefe CC, Goldman MM, Zhang K, Clarke N, Reitz RE, Welt CK. PLoS One; 2014 Jul 02; 9(4):e93805. PubMed ID: 24713888 [Abstract] [Full Text] [Related]
12. Increased Prevalence of Elevated DHEAS in PCOS Women with Non-Classic (B or C) Phenotypes: A Retrospective Analysis in Patients Aged 20 to 29 Years. Carmina E, Longo RA. Cells; 2022 Oct 17; 11(20):. PubMed ID: 36291122 [Abstract] [Full Text] [Related]
14. Hyperandrogenic environment regulates the function of ovarian granulosa cells by modulating macrophage polarization in PCOS. Chen X, Hong L, Diao L, Yin T, Liu S. Am J Reprod Immunol; 2024 May 17; 91(5):e13854. PubMed ID: 38716832 [Abstract] [Full Text] [Related]
15. Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome. Henríquez S, Kohen P, Xu X, Villarroel C, Muñoz A, Godoy A, Strauss JF, Devoto L. Hum Reprod; 2020 Jul 01; 35(7):1655-1665. PubMed ID: 32558920 [Abstract] [Full Text] [Related]
16. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause. Markopoulos MC, Rizos D, Valsamakis G, Deligeoroglou E, Grigoriou O, Chrousos GP, Creatsas G, Mastorakos G. J Clin Endocrinol Metab; 2011 Mar 01; 96(3):623-31. PubMed ID: 21177795 [Abstract] [Full Text] [Related]
17. The serum steroid signature of PCOS hints at the involvement of novel pathways for excess androgen biosynthesis. Altinkilic EM, du Toit T, Sakin Ö, Attar R, Groessl M, Flück CE. J Steroid Biochem Mol Biol; 2023 Oct 01; 233():106366. PubMed ID: 37499841 [Abstract] [Full Text] [Related]